Relative Intelligence · Consumer Health

How Haleon (HLN) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on HLN alone. It places HLN (Haleon plc) against 20+ popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where HLN stands in the market, and of the alternatives worth a closer look.
Period covered: HLN's full trading record, from July 2022 through September 2026. The crash tests reach back to 2000 using older funds and the S&P 500. All returns include reinvested dividends. Data as of October 22, 2026.
Data as of October 22, 2026. Full tables and charts read best on a larger screen.
This page answers the following questions about HLN
Key findings
Not AI-generatedThese key findings are generated by our proprietary relative intelligence engine, directly from the data on this page.
- Right nowHLN has bounced back 19.9% from its June 2026 low after a 23.2% loss from June 2025 to June 2026 over the same months the S&P 500 rose 29.6%. Its consumer health peers split over the past 6 months: EL (Estée Lauder Companies) rose 41.6%, while HLF (Herbalife Nutrition) fell 16.5%. Consistency ↓
- Stock or market?HLN lagged its own industry over the past 3 months, rising 5.9% while the consumer health ETF XLV (State Street Health Care Select Sector SPDR ETF) rose 14.2%. The S&P 500 rose 2.5%. On the flip side, last month cut against the tape: HLN rose 12.1% while the S&P 500 fell 1.2%.
- Past 1 to 3 yearsOver the past year, HLN rose 10.4% against 15.6% for the S&P 500 and 16.9% for the Nasdaq 100. The same gap shows up over 3 years (30.8% against 88.4%). The last two calendar years both went the same way: HLN rose 7.8% in 2025, against 15.6% for the S&P 500 and 16.9% for the Nasdaq 100. By year ↓
- Long termHLN turned $10,000 into $13,100 over the past 3 years, against $18,800 in the S&P 500. That said, over the past 3 years, only CL (Colgate-Palmolive) of its consumer health peers outpaced HLN. Growth of $10,000 ↓
- DiversificationOver 3 years, HLN's beta versus the S&P 500 was 0.04: 33% of the S&P 500's gains in rising months and 68% of its losses in falling ones. On the flip side, against the S&P 500, HLN has a correlation of 0.02 over 3 years, less closely than 93% of stocks worth at least $300 million. Next to an index fund it is a real diversifier. Market capture ↓
- Better options
- Nearby categories and themes
- JNJ (Johnson & Johnson, pharmaceuticals) and COST (Costco Wholesale, discount retail) earned more than HLN with less volatility over the past 3 years. JNJ returned 24.4% a year at 18.5% volatility, against 9.4% a year at 21.6%.
- Whole market
- 757 of the 3,931 stocks and funds worth at least $500 million earned more than HLN with less volatility over the past 3 years, among them VTI (Vanguard Morningstar Total Stock Market ETF), VOO (Vanguard S&P 500 ETF) and BRK-A (Berkshire Hathaway).
How much would $10,000 in HLN have grown?
This chart tracks a hypothetical $10,000 investment in HLN over the past 4 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of HLN over the same span and HLN's popular alternatives, among those that traded for the entire period. It shows not only where each investment ended up but also how smooth or uneven the path was.
Note: HLN began trading on July 18, 2022, so the chart cannot reach back to the dot-com bust, the 2008 financial crisis or six other sell-offs. It covers the most recent 4 years of HLN's record, starting at the end of September 2022.
- $10,000 invested in HLN at the end of September 2022 would have grown to $15,598 by September 2026, less than the $22,487 it would have become in SPY, an S&P 500 fund.
- Five of the eight other investments on the chart ended ahead of HLN, and ELF finished highest, at $26,841.
From the end of September 2022 to the end of September 2026. Hover over a fund in the key to pick out its line. 2,049 of the 3,776 stocks and funds worth at least $500 million that traded the whole period ended ahead of HLN; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- ELF$26,841+168% total · +28.0% a year
- WMT$25,187+152% total · +26.0% a year
- SPY (S&P 500)$22,487+125% total · +22.5% a year
- COST$20,209+102% total · +19.2% a year
- GSK$19,145+91.5% total · +17.6% a year
- JNJ$18,155+81.5% total · +16.1% a year
- HLN$15,598+56.0% total · +11.8% a year
- CL$13,367+33.7% total · +7.5% a year
- TGT$12,120+21.2% total · +4.9% a year
- CVS$10,374+3.7% total · +0.9% a year
HLN at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
Note: HLN began trading on July 18, 2022, so every figure here, including its worst decline, covers only the time since then. None of them reflect the dot-com bust, the 2008 financial crisis or six other sell-offs.
- HLN has not had a losing calendar year since it began trading in 2022; it gained in all three full years, at worst 4.1% in 2023.
- HLN's deepest decline since it began trading in 2022 was 24.9%, from July to September 2022. It took three months from the low to climb back to its old high.
- HLN is 8.0% below its all-time high.
The company
- Market value
- $46B
- Industry
- Drug Manufacturers - Specialty & Generic
- Price history from
- July 2022
Returns
- Past 1 year
- +10.4%total return
- Past 3 years
- +30.8%+9.4% a year
- Best calendar year
- +18.1%2024
- Worst calendar year
- +4.1%2023
- Losing years
- 0 of 3full calendar years
Risk
- Volatility
- 21.6%typical yearly swing, 3 years
- Sharpe ratio
- 0.52return per unit of risk, 3 years
- Worst decline ever
- −24.9%Jul 2022 to Sep 2022
- From its all-time high
- −8.0%below the peak
HLN against the whole market
Where HLN ranks among every stock and fund, and what across the market has done better.
How does HLN rank among all stocks?
This section ranks HLN on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how HLN stacks up against its peers, these rankings show where it stands in the market as a whole.
- HLN is among the steadier stocks: its price swings rank in the top 7% of the 3,016 stocks worth at least $300 million, where the top is the calmest.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | HLN | Rank | Standing |
|---|---|---|---|
| 1-year return | +10.4% | 1,616 of 3,282 | top 49% |
| 3-year return | +30.8% | 1,879 of 3,016 | bottom 39% |
| Volatility, 3 years | 21.6% | 214 of 3,016 | top 7% |
| Sharpe ratio, 3 years | 0.52 | 1,752 of 3,016 | bottom 43% |
What has beaten HLN on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 3 years (higher is better) and how much its price swung, its volatility (further left is calmer). HLN sits where the dashed lines cross. Anything in the green box above and to the left earned more than HLN with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 89 stocks and 668 ETFs worth at least $500 million sit in the green region: each earned more than HLN over the past 3 years with smaller price swings. That is 19% of the 3,931 screened.
- Among those with at least half HLN's swings, WCCB has the best return for its risk: 38.2% a year at 13.8% volatility, 36% less than HLN's 21.6%, and a Sharpe ratio (return above cash per unit of volatility) of 2.42 against 0.52 for HLN. CM earned the most, 54.0% a year, while still swinging less than HLN (19.8% against 21.6%).
- Among HLN's popular alternatives, CL is in the region. CL earned 13.2% a year against 9.4% a year for HLN, at 19.9% volatility, 8% less than HLN's 21.6%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 3 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to HLN; faint dots are 92 more of the 757 in the green region (the strongest, one per fund family). 3,931 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
Is there a better investment than HLN?
Investments that beat HLN over the past 3 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among HLN's popular alternatives, CL earned more than HLN with less volatility over the past 3 years: 13.2% a year at 19.9% volatility, against 9.4% a year at 21.6%.
- Looking beyond its popular alternatives, JNJ (pharmaceuticals) and COST (discount retail) earned more than HLN with less volatility over the past 3 years. JNJ returned 24.4% a year at 18.5% volatility, against 9.4% a year at 21.6%.
- Across the whole market, 757 of the 3,931 stocks and funds worth at least $500 million earned more than HLN with less volatility over the past 3 years, among them VTI, VOO and BRK-A.
How this works
The table below lists investments that beat HLN over the past 3 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks HLN's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than HLN follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 3 years; the worst decline covers the past 10 years. Green marks a better figure than HLN's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× HLN's volatility counts as better.
These figures cover the past 3 years. Green marks a better figure than HLN's.
| Investment | Why it is better | Past 3 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 3Y returntotal | Corr. with HLN?lower diversifies more | Expenseper year | |||
| +9.4% | 21.6% | 0.52 | −24.9% | +30.8% | 1.00 | — | |||
| +23.5% | 15.3% | 1.47 | −33.7% | +88.4% | 0.02 | 0.09% | |||
| Popular alternativesbest 2 shownThe investments people most often weigh against HLN. 2 of 20 passed at least one test. | |||||||||
| Higher return, lower volatility | +13.2% | 19.9% | 0.73 | −29.0% | +45.1% | 0.56 | — | ||
| Higher return, similar volatility | +32.6% | 23.3% | 1.33 | −25.7% | +133% | 0.12 | — | ||
| Same and neighboring categories, and shared themesbest 6 shownEverything else in Consumer Health and the categories next to it (Household & Personal Products, Nutritional Supplements, Pharmaceuticals, Discount Retail), plus HLN's specific themes. 10 of 58 passed at least one test. | |||||||||
| Higher return, lower volatility | +24.4% | 18.5% | 1.28 | −27.4% | +92.5% | 0.41 | — | ||
| Higher return, lower volatility | +24.3% | 20.4% | 1.17 | −31.4% | +91.8% | 0.29 | — | ||
| Higher return, lower volatility | +16.6% | 20.1% | 0.87 | −54.4% | +58.4% | 0.49 | — | ||
| Higher return, lower volatility | +10.7% | 20.1% | 0.61 | −30.1% | +35.5% | 0.64 | — | ||
IHEiShares U.S. Pharmaceuticals ETF · Pharmaceuticals | Higher return, lower volatility | +24.2% | 17.3% | 1.34 | −29.6% | +91.4% | 0.37 | 0.37% | |
| Higher return, similar volatility | +21.4% | 21.8% | 1.01 | −26.8% | +78.9% | 0.51 | — | ||
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 980 of 3,862 passed at least one test. | |||||||||
BUFRFT Vest Laddered Buffer ETF · Buffered Equity | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +15.9% | 8.6% | 1.76 | −13.7% | +55.5% | 0.07 | 0.10% | |
PSEPInnovator U.S. Equity Power Buffer ETF · Moderate Buffer | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +13.5% | 7.3% | 1.79 | −17.9% | +46.2% | 0.08 | 0.79% | |
XEMDBondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF · Emerging Market Bonds | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +10.8% | 5.5% | 1.90 | −10.0% | +36.0% | 0.39 | 0.29% | |
BUFZFT Vest Laddered Moderate Buffer ETF · US Equity Buffer | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +13.4% | 7.0% | 1.84 | −10.1% | +45.8% | — | 0.10% | |
DCORU.S. Core Equity 1 Portfolio ETF Class Shares · US Total Market | Higher return, lower volatilityHigher Sharpe, smaller worst decline | +22.8% | 14.8% | 1.47 | −19.1% | +85.2% | 0.11 | 0.17% | |
| On the frontierHigher return, lower volatility | +40.2% | 16.9% | 2.09 | −40.0% | +176% | 0.26 | — | ||
PYLDPIMCO Multisector Bond Active Exchange-Traded Fund · Multisector Bonds | Similar return, lower volatilityHigher Sharpe, smaller worst decline | +8.7% | 3.8% | 2.24 | −4.5% | +28.4% | 0.36 | 0.74% | |
| On the frontierHigher return, similar volatility | +55.6% | 21.2% | 2.21 | −50.5% | +277% | 0.18 | — | ||
What these numbers mean for HLN
- Annual return
- HLN returned 9.4% a year over the past 3 years with dividends reinvested, against 23.5% a year for the S&P 500. At that pace, $10,000 became about $13,100. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- HLN's volatility over the past 3 years was 21.6%, 1.4 times the S&P 500's 15.2%. Volatility measures how widely returns swing around their average: in roughly two years out of three, HLN's return lands within 21.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- HLN's Sharpe ratio over the past 3 years was 0.52, against 1.47 for the S&P 500, so HLN earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- HLN's worst fall from a peak to a low over the past 10 years was 24.9%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 24.9% fall takes a 33.1% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 3 years, HLN's monthly returns had a correlation of 0.02 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are close to unrelated, or move in opposite directions, so it can steady a stock portfolio. In the table, the correlation column measures each option against HLN instead: the lower it is, the more that option would diversify a HLN holding. Guide: Correlation and diversification →
Show all 757 stocks and funds worth at least $500 million that earned more than HLN with less volatility
Out of 3,931 tested over 3 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 3Y return | Corr. with HLN | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BUFRFT Vest Laddered Buffer ETF · Buffered Equity | Whole market | +15.9% | 8.6% | 1.76 | −13.7% | +55.5% | 0.07 | 0.10% |
| 2 | PSEPInnovator U.S. Equity Power Buffer ETF · Moderate Buffer | Whole market | +13.5% | 7.3% | 1.79 | −17.9% | +46.2% | 0.08 | 0.79% |
| 3 | XEMDBondBloxx JP Morgan USD Emerging Markets 1-10 Year Bond ETF · Emerging Market Bonds | Whole market | +10.8% | 5.5% | 1.90 | −10.0% | +36.0% | 0.39 | 0.29% |
| 4 | BUFZFT Vest Laddered Moderate Buffer ETF · US Equity Buffer | Whole market | +13.4% | 7.0% | 1.84 | −10.1% | +45.8% | — | 0.10% |
| 5 | DCORU.S. Core Equity 1 Portfolio ETF Class Shares · US Total Market | Whole market | +22.8% | 14.8% | 1.47 | −19.1% | +85.2% | 0.11 | 0.17% |
| 6 | PDECInnovator U.S. Equity Power Buffer ETF · US Equity Buffer | Whole market | +14.1% | 7.7% | 1.76 | −19.3% | +48.5% | 0.04 | 0.79% |
| 7 | Whole market | +40.2% | 16.9% | 2.09 | −40.0% | +176% | 0.26 | — | |
| 8 | Whole market | +11.4% | 10.0% | 1.14 | −13.7% | +38.4% | 0.43 | 0.35% | |
| 9 | AVLVAvantis U.S. Large Cap Value ETF · US Large-Cap Value | Whole market | +24.1% | 14.8% | 1.54 | −19.5% | +91.1% | 0.19 | 0.15% |
| 10 | VFLOVictoryShares Free Cash Flow ETF · US Large-Cap Value | Whole market | +31.3% | 16.4% | 1.76 | −17.8% | +127% | 0.27 | 0.44% |
| 11 | DFUVDimensional - US Marketwide Value ETF · US Value Equity | Whole market | +22.2% | 14.2% | 1.49 | −17.6% | +82.5% | 0.23 | 0.21% |
| 12 | Whole market | +54.0% | 19.8% | 2.29 | −47.3% | +265% | 0.24 | — | |
| 13 | SPYINeos S&P 500(R) High Income ETF · Equity Income | Whole market | +18.1% | 12.5% | 1.40 | −16.5% | +64.9% | 0.06 | 0.68% |
| 14 | TCAFT. Rowe Capital Appreciation Equity ETF · Active Core Equity | Whole market | +21.2% | 14.0% | 1.45 | −16.4% | +78.0% | 0.01 | 0.31% |
| 15 | JAVAJPMorgan Active Value ETF · US Large-Cap Value | Whole market | +20.4% | 12.9% | 1.51 | −16.5% | +74.5% | 0.25 | 0.44% |
| 16 | CGBLCapital Group Core Balanced ETF · Balanced Allocation | Whole market | +16.5% | 10.9% | 1.46 | −11.7% | +58.1% | 0.14 | 0.33% |
| 17 | JIVEJPMorgan International Value ETF · International Large-Cap Value | Whole market | +28.9% | 14.9% | 1.79 | −13.8% | +114% | 0.47 | 0.55% |
| 18 | JIREJPMorgan International Research Enhanced Equity ETF · Developed International Equity | Whole market | +19.0% | 15.4% | 1.21 | −16.1% | +68.5% | 0.52 | 0.29% |
| 19 | GPIXGoldman Sachs S&P 500 Premium Income ETF · Covered Call Income | Whole market | +21.7% | 13.5% | 1.54 | −17.5% | +80.4% | — | 0.35% |
| 20 | CGDGCapital Group Dividend Growers ETF · Global Equity | Whole market | +18.5% | 11.8% | 1.51 | −10.5% | +66.5% | 0.48 | 0.47% |
| 21 | HELOJPMorgan Hedged Equity Laddered Overlay ETF · Hedged Equity | Whole market | +12.5% | 7.8% | 1.55 | −10.9% | +42.4% | 0.14 | 0.50% |
| 22 | JGLOJPMorgan Global Select Equity ETF · Global Equity | Whole market | +17.3% | 13.9% | 1.22 | −16.1% | +61.2% | 0.14 | 0.47% |
| 23 | INCMFranklin Income Focus ETF · Multi-Asset Income | Whole market | +13.2% | 7.2% | 1.77 | −7.8% | +45.2% | 0.38 | 0.38% |
| 24 | RDVIFT Vest Rising Dividend Achievers Target Income ETF · Covered Call Income | Whole market | +22.0% | 15.8% | 1.34 | −18.4% | +81.5% | 0.18 | 0.75% |
| 25 | SEIVSEI QiM U.S. Large Cap Value Active ETF · US Large-Cap Value | Whole market | +29.4% | 14.7% | 1.83 | −18.2% | +117% | 0.16 | 0.15% |
| 26 | FOCTFT Vest U.S. Equity Buffer ETF - October · S&P 500 Buffer | Whole market | +15.0% | 9.1% | 1.58 | −14.1% | +52.1% | 0.03 | 0.85% |
| 27 | BGIGBahl & Gaynor Income Growth ETF · Dividend Growth | Whole market | +19.3% | 11.5% | 1.61 | −13.3% | +69.9% | 0.37 | 0.45% |
| 28 | SFLRInnovator Equity Managed Floor ETF · Buffered Equity | Whole market | +16.3% | 10.1% | 1.56 | −12.1% | +57.2% | -0.03 | 0.89% |
| 29 | ACIOAptus Collared Income Opportunity ETF · Hedged Equity | Whole market | +16.2% | 10.3% | 1.52 | −14.2% | +56.7% | 0.05 | 0.79% |
| 30 | Whole market | +23.6% | 14.8% | 1.51 | −34.0% | +88.8% | 0.03 | 0.03% | |
| 31 | BKGIBNY Mellon Global Infrastructure Income ETF · Infrastructure Equity | Whole market | +22.7% | 13.2% | 1.63 | −14.8% | +84.9% | 0.48 | 0.65% |
| 32 | CLSEConvergence Long/Short Equity ETF · Long-Short Equity | Whole market | +28.4% | 13.8% | 1.89 | −16.4% | +112% | -0.14 | 1.52% |
| 33 | DFAWDimensional - World Equity ETF · Global Equity | Whole market | +21.9% | 14.2% | 1.48 | −16.9% | +81.3% | 0.21 | 0.24% |
| 34 | JPEFJPMorgan Equity Focus ETF · Concentrated Equity | Whole market | +20.9% | 14.9% | 1.36 | −18.1% | +76.8% | 0.06 | 0.55% |
| 35 | DFEVDimensional - Emerging Markets Value ETF · International Equity | Whole market | +24.2% | 18.0% | 1.30 | −18.5% | +91.4% | 0.08 | 0.46% |
| 36 | TDVGT. Rowe Price Dividend Growth ETF · Dividend Growth | Whole market | +18.2% | 11.8% | 1.48 | −19.2% | +65.0% | 0.35 | 0.50% |
| 37 | TOUST. Rowe Price International Equity ETF · International Large-Cap Equity | Whole market | +20.5% | 15.3% | 1.31 | −14.3% | +75.1% | 0.48 | 0.50% |
| 38 | DOCTFT Vest U.S. Equity Deep Buffer ETF - October · Deep Buffer | Whole market | +12.3% | 6.7% | 1.77 | −9.9% | +41.5% | 0.01 | 0.85% |
| 39 | IDVOAmplify CWP International Enhanced Dividend Income ETF · Equity Income | Whole market | +22.4% | 16.0% | 1.35 | −15.5% | +83.2% | 0.31 | 0.65% |
| 40 | PMAYInnovator U.S. Equity Power Buffer ETF - May · S&P 500 Buffer | Whole market | +13.1% | 7.5% | 1.69 | −13.0% | +44.8% | 0.16 | 0.79% |
| 41 | CGIECapital Group International Equity ETF · Active International Equity | Whole market | +15.6% | 15.5% | 1.01 | −13.8% | +54.3% | 0.45 | 0.54% |
| 42 | SIXAETC 6 Meridian Mega Cap Equity ETF · US Large-Cap Equity | Whole market | +23.0% | 11.2% | 1.93 | −18.4% | +86.3% | 0.39 | 0.31% |
| 43 | AOKiShares Core 30/70 Conservative Allocation ETF · Balanced Allocation | Whole market | +10.5% | 6.3% | 1.62 | −18.9% | +34.7% | 0.28 | 0.20% |
| 44 | EQTYKovitz Core Equity ETF · Active Core Equity | Whole market | +19.2% | 14.3% | 1.30 | −17.3% | +69.2% | 0.21 | 0.99% |
| 45 | FDVFederated Hermes U.S. Strategic Dividend ETF · High Dividend Yield | Whole market | +20.3% | 12.7% | 1.53 | −16.7% | +74.0% | 0.49 | 0.61% |
| 46 | SMRIBushido Capital US Equity ETF · Active Core Equity | Whole market | +27.6% | 15.8% | 1.63 | −18.5% | +108% | 0.24 | 0.71% |
| 47 | Whole market | +17.0% | 15.9% | 1.07 | −30.4% | +60.2% | 0.46 | — | |
| 48 | FTQIFirst Trust Nasdaq BuyWrite Income ETF · Nasdaq Options Income | Whole market | +18.6% | 13.6% | 1.33 | −19.5% | +67.0% | -0.16 | 0.75% |
| 49 | SMIGBahl & Gaynor Small/Mid Cap Income Growth ETF · US Dividend Equity | Whole market | +15.3% | 14.3% | 1.07 | −19.7% | +53.3% | 0.31 | 0.60% |
| 50 | AVNMAvantis All International Markets Equity ETF · International Multifactor Equity | Whole market | +22.8% | 15.2% | 1.44 | −14.0% | +85.2% | 0.38 | 0.31% |
| 51 | SIXHETC 6 Meridian Hedged Equity Index Option ETF · Hedged Equity | Whole market | +14.5% | 8.9% | 1.57 | −11.7% | +50.2% | 0.47 | 0.31% |
| 52 | PMTUPennyMac Mortgage Investment Trust · Mortgage REITs | Whole market | +10.6% | 6.6% | 1.58 | −2.9% | +35.2% | 0.12 | — |
| 53 | Whole market | +20.5% | 15.4% | 1.30 | −36.0% | +75.1% | 0.36 | 0.05% | |
| 54 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Dividend Equity | Whole market | +24.5% | 10.6% | 2.12 | −32.4% | +92.8% | 0.58 | 0.40% |
| 55 | BINVBrandes International ETF · International Large-Cap Value | Whole market | +24.4% | 14.5% | 1.59 | −14.9% | +92.3% | — | 0.70% |
| 56 | SCCESachem Capital Corp. 6.00% Note · Corporate Bonds | Whole market | +17.3% | 15.2% | 1.13 | −19.9% | +61.2% | -0.09 | — |
| 57 | BRNYBurney U.S. Factor Rotation ETF · US Multifactor Equity | Whole market | +27.2% | 17.0% | 1.51 | −19.1% | +106% | -0.01 | 0.79% |
| 58 | SEIQSEI QiM U.S. Large Cap Quality Active ETF · US Large-Cap Equity | Whole market | +17.7% | 12.8% | 1.34 | −14.9% | +62.9% | 0.25 | 0.15% |
| 59 | Whole market | +22.3% | 20.4% | 1.10 | −36.4% | +83.1% | 0.33 | — | |
| 60 | QMARFT Vest Nasdaq-100 Buffer ETF - March · Nasdaq-100 Buffer | Whole market | +16.5% | 11.2% | 1.43 | −19.8% | +58.1% | -0.15 | 0.90% |
| 61 | IDViShares International Select Dividend ETF · International Dividend Equity | Whole market | +27.0% | 13.7% | 1.83 | −42.5% | +105% | 0.48 | 0.50% |
| 62 | Whole market | +24.3% | 16.4% | 1.41 | −37.0% | +92.2% | 0.67 | — | |
| 63 | CMDTPIMCO Commodity Strategy Active Exchange-Traded Fund · Broad Commodities | Whole market | +14.2% | 12.4% | 1.14 | −13.2% | +48.9% | -0.22 | 0.98% |
| 64 | EIPXFT Energy Income Partners Strategy ETF · Energy Infrastructure | Whole market | +20.1% | 14.2% | 1.37 | −15.4% | +73.1% | 0.25 | 0.95% |
| 65 | Whole market | +35.2% | 18.4% | 1.75 | −42.0% | +147% | 0.26 | — | |
| 66 | BBEMJPMorgan BetaBuilders Emerging Markets Equity ETF · Emerging Markets Equity | Whole market | +20.5% | 19.5% | 1.06 | −17.4% | +75.0% | 0.06 | 0.15% |
| 67 | Whole market | +25.2% | 19.8% | 1.24 | −35.6% | +96.1% | -0.14 | 0.03% | |
| 68 | Whole market | +38.4% | 18.2% | 1.89 | −46.9% | +165% | 0.29 | — | |
| 69 | PAPIParametric Equity Premium Income ETF · Covered Call Income | Whole market | +13.1% | 11.5% | 1.13 | −14.3% | +44.5% | — | 0.29% |
| 70 | Whole market | +19.5% | 14.6% | 1.30 | −39.4% | +70.7% | 0.22 | 0.03% | |
| 71 | Whole market | +35.8% | 20.3% | 1.62 | −51.0% | +150% | 0.09 | — | |
| 72 | DIVBiShares Core Dividend ETF · High Dividend Yield | Whole market | +29.0% | 13.7% | 1.94 | −36.9% | +115% | 0.32 | 0.05% |
| 73 | Whole market | +19.9% | 13.2% | 1.45 | −33.4% | +72.3% | 0.39 | 0.06% | |
| 74 | Whole market | +17.8% | 16.5% | 1.08 | −36.4% | +63.5% | 0.16 | 0.06% | |
| 75 | Whole market | +19.0% | 18.7% | 1.03 | −42.0% | +68.6% | 0.16 | 0.03% | |
| 76 | Whole market | +22.4% | 19.1% | 1.16 | −42.6% | +83.3% | 0.56 | — | |
| 77 | Whole market | +20.2% | 18.9% | 1.07 | −42.5% | +73.5% | 0.14 | — | |
| 78 | WCCBWest Coast Community Bancorp · Regional Banks | Whole market | +38.2% | 13.8% | 2.42 | −70.8% | +164% | 0.00 | — |
| 79 | Whole market | +33.1% | 18.9% | 1.61 | −41.6% | +136% | 0.29 | — | |
| 80 | Whole market | +22.2% | 16.8% | 1.29 | −44.1% | +82.7% | 0.35 | — | |
| 81 | Whole market | +18.9% | 13.8% | 1.33 | −39.0% | +68.3% | 0.33 | 0.20% | |
| 82 | FGDFirst Trust Dow Jones Global Select Dividend Index Fund · Global Equity | Whole market | +25.7% | 12.9% | 1.84 | −44.8% | +98.6% | 0.48 | 0.55% |
| 83 | Whole market | +13.2% | 17.8% | 0.79 | −32.6% | +45.1% | 0.37 | — | |
| 84 | Whole market | +27.2% | 16.8% | 1.53 | −75.2% | +106% | 0.32 | — | |
| 85 | Whole market | +25.2% | 13.7% | 1.72 | −21.8% | +96.5% | 0.21 | 0.33% | |
| 86 | Whole market | +25.7% | 19.1% | 1.29 | −32.9% | +98.5% | 0.25 | — | |
| 87 | Whole market | +26.8% | 15.8% | 1.60 | −34.7% | +104% | 0.03 | 0.26% | |
| 88 | Whole market | +17.6% | 16.8% | 1.06 | −37.4% | +62.6% | 0.29 | — | |
| 89 | Whole market | +23.7% | 20.3% | 1.15 | −43.7% | +89.4% | 0.53 | — | |
| 90 | Whole market | +16.7% | 17.6% | 0.97 | −38.4% | +59.0% | 0.25 | — | |
| 91 | Whole market | +20.8% | 20.0% | 1.05 | −41.7% | +76.3% | 0.07 | 0.05% | |
| 92 | Whole market | +17.6% | 20.2% | 0.91 | −37.4% | +62.8% | 0.40 | — | |
| 93 | Whole market | +22.9% | 16.1% | 1.37 | −42.9% | +85.5% | 0.31 | 0.08% | |
| 94 | Whole market | +29.2% | 20.4% | 1.36 | −48.8% | +116% | 0.40 | — | |
| 95 | Whole market | +20.1% | 17.7% | 1.13 | −34.0% | +73.3% | 0.48 | — | |
| 96 | Whole market | +17.6% | 16.5% | 1.07 | −58.1% | +62.8% | 0.24 | — | |
| 97 | VOEVanguard Morningstar Mid-Cap Value ETF · Mid-Cap Value | Whole market | +21.3% | 13.6% | 1.50 | −43.2% | +78.6% | 0.37 | 0.05% |
| 98 | Whole market | +17.1% | 19.2% | 0.92 | −30.1% | +60.5% | 0.27 | — | |
| 99 | Whole market | +18.9% | 13.7% | 1.34 | −36.7% | +68.1% | 0.22 | 0.16% | |
| 100 | Whole market | +25.8% | 18.6% | 1.33 | −50.8% | +99.2% | 0.34 | — |
HLN against its popular alternatives
The investments people most often weigh against HLN, compared period by period and year by year.
How do HLN's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 3 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at HLN, which divides the map into what did better or worse on each measure.
- Only CL was both more rewarding and calmer than HLN over the past 3 years, earning a higher annual return with lower volatility.
- 13 of the 20 popular alternatives earned less than HLN over the past 3 years while swinging more, the weaker corner of the map.
- Over the past 3 years, HLN returned 9.3% a year, less than the S&P 500's 23.5%, with higher volatility (21.6% against 15.2%).
Green points earned more than HLN with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| WMT Walmart Inc. | +32.6% | 23.3% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +23.5% | 15.3% |
| TGT Target Corporation | +18.0% | 35.3% |
| GSK GSK plc | +17.2% | 25.4% |
| CVS CVS Health Corp. | +15.3% | 33.4% |
| CL Colgate-Palmolive Company | +13.2% | 19.9% |
| HLN This pageHaleon plc | +9.3% | 21.6% |
| CHD Church & Dwight Co., Inc. | +7.4% | 20.6% |
| PG The Procter & Gamble Company | +6.3% | 18.3% |
| PFE Pfizer Inc. | +6.2% | 24.1% |
| KVUE Kenvue Inc. | +5.0% | 28.6% |
| ELF e.l.f. Beauty, Inc. | +2.9% | 65.0% |
| HLF Herbalife Nutrition Ltd. | +0.4% | 64.3% |
| NWL Newell Brands Inc. | −0.7% | 63.1% |
| PBH Prestige Consumer Healthcare Inc. | −5.7% | 28.3% |
| EL The Estée Lauder Companies Inc. | −6.0% | 48.7% |
| CLX The Clorox Company | −6.6% | 25.6% |
| NATR Nature's Sunshine Products, Inc. | −11.5% | 45.9% |
| PRGO Perrigo Company plc | −12.6% | 43.5% |
| COTY Coty Inc. | −30.2% | 45.2% |
| NUS Nu Skin Enterprises, Inc. | −34.3% | 53.4% |
| USNA USANA Health Sciences, Inc. | −35.7% | 46.5% |
Has HLN consistently beaten its popular alternatives?
This section compares HLN with the investments people most often weigh against it, checking each one over six periods from one month to three years. Counting how often an alternative earned more than HLN helps separate lasting outperformance from a single strong stretch.
- Four of the 20 popular alternatives, led by TGT, CL and WMT, outperformed HLN in at least 3 of 5 short-term and 1 of 1 long-term timeframes.
- TGT and CL outperformed HLN in every long-term period and in all but one short-term period, the most consistent record in the group.
A green cell means the alternative earned more than HLN over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 1 of 1 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 3 years | Fund | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| HLN Haleon plc (this page) | — | +12.1% | +5.9% | +11.5% | +4.3% | +10.4% | +30.8% | 21.6% | 0.52 | −24.9% | — | $46B | — |
| TGT QualifiedTarget Corporation | 4/5 short1/1 longAll-weather | −0.6% | +15.5% | +23.1% | +61.7% | +75.0% | +64.3% | 35.3% | 0.65 | −64.4% | — | $72B | — |
| CL QualifiedColgate-Palmolive Company | 4/5 short1/1 longAll-weather | +12.5% | +6.9% | +19.6% | +28.4% | +24.9% | +45.1% | 19.9% | 0.73 | −29.0% | — | $78B | — |
| WMT QualifiedWalmart Inc. | 3/5 short1/1 long | +10.0% | +11.0% | −6.4% | +8.1% | +14.0% | +133% | 23.3% | 1.33 | −25.7% | — | $964B | — |
| CVS QualifiedCVS Health Corp. | 3/5 short1/1 long | +9.3% | −11.4% | +26.4% | +21.5% | +19.7% | +53.4% | 33.4% | 0.60 | −56.8% | — | $121B | — |
| GSK Drug Manufacturers - GeneralGSK plc | 2/5 short1/1 long | +1.0% | +1.8% | −6.4% | +5.9% | +19.8% | +60.8% | 25.4% | 0.76 | −37.6% | — | $103B | — |
| CHD Household & Personal ProductsChurch & Dwight Co., Inc. | 5/5 short0/1 long | +13.3% | +12.4% | +17.9% | +33.0% | +25.1% | +24.0% | 20.6% | 0.45 | −31.7% | — | $26B | — |
| PG Household & Personal ProductsThe Procter & Gamble Company | 4/5 short0/1 long | +11.7% | +11.9% | +17.7% | +19.4% | +12.0% | +20.2% | 18.3% | 0.43 | −23.8% | — | $385B | — |
| PFE Drug Manufacturers - GeneralPfizer Inc. | 4/5 short0/1 long | +8.9% | +24.7% | +17.4% | +27.0% | +31.7% | +19.6% | 24.1% | 0.37 | −58.9% | — | $173B | — |
| HLF Packaged FoodsHerbalife Nutrition Ltd. | 4/5 short0/1 long | +12.7% | +13.0% | −16.5% | +7.5% | +57.5% | +1.3% | 64.3% | 0.32 | −91.7% | — | $1.4B | — |
| NWL Household & Personal ProductsNewell Brands Inc. | 4/5 short0/1 long | −0.7% | +7.5% | +43.6% | +61.4% | +25.9% | −2.1% | 63.1% | 0.30 | −91.8% | — | $2.4B | — |
| PRGO Drug Manufacturers - Specialty & GenericPerrigo Company plc | 4/5 short0/1 long | +14.4% | +59.6% | +45.1% | +26.2% | −17.2% | −33.2% | 43.5% | -0.09 | −87.6% | — | $2.3B | — |
| KVUE Household & Personal ProductsKenvue Inc. | 3/5 short0/1 long | +11.3% | +6.3% | +18.9% | +20.2% | +38.8% | +15.8% | 28.6% | 0.31 | −44.1% | — | $38B | — |
| ELF Household & Personal Productse.l.f. Beauty, Inc. | 3/5 short0/1 long | +12.6% | +45.5% | +75.3% | +47.8% | −7.0% | +9.0% | 65.0% | 0.38 | −77.3% | — | $6.8B | — |
| COTY Household & Personal ProductsCoty Inc. | 3/5 short0/1 long | +20.2% | +17.6% | +39.0% | +3.2% | −22.8% | −66.0% | 45.2% | -0.57 | −90.9% | — | $2.8B | — |
| EL Household & Personal ProductsThe Estée Lauder Companies Inc. | 2/5 short0/1 long | +7.4% | +30.8% | +41.6% | +2.0% | +10.8% | −16.9% | 48.7% | 0.12 | −85.8% | — | $39B | — |
| PBH Medical - PharmaceuticalsPrestige Consumer Healthcare Inc. | 0/5 short0/1 long | +3.6% | +0.9% | −13.5% | −19.2% | −21.9% | −16.2% | 28.3% | -0.07 | −53.2% | — | $2.3B | — |
| CLX Household & Personal ProductsThe Clorox Company | 0/5 short0/1 long | +1.7% | −6.3% | −7.4% | −8.9% | −22.3% | −18.5% | 25.6% | -0.14 | −58.8% | — | $11B | — |
| NATR Packaged FoodsNature's Sunshine Products, Inc. | 0/5 short0/1 long | −6.1% | −40.4% | −53.9% | −40.8% | −13.2% | −30.7% | 45.9% | -0.04 | −61.6% | — | $218M | — |
| NUS Household & Personal ProductsNu Skin Enterprises, Inc. | 0/5 short0/1 long | +1.2% | −4.3% | −32.7% | −47.7% | −53.1% | −71.6% | 53.4% | -0.52 | −93.0% | — | $239M | — |
| USNA Packaged FoodsUSANA Health Sciences, Inc. | 0/5 short0/1 long | −1.8% | −34.5% | −25.6% | −25.3% | −30.6% | −73.4% | 46.5% | -0.70 | −90.6% | — | $268M | — |
How did HLN do year by year?
This table shows each investment's total return in every full calendar year since 2023, along with where HLN ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with HLN and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
Note: HLN began trading on July 18, 2022, so the table starts with 2023, its first full calendar year, and cannot show how it fared during the dot-com bust, the 2008 financial crisis or six other sell-offs.
- HLN finished ahead of the S&P 500 in no of its three full calendar years, and behind it in each of the last three.
- Among its popular alternatives, WMT came out ahead of HLN most often, in all three years both traded.
- Ranked against its popular alternatives each year, HLN finished in the top quarter in one of three years and in the bottom quarter in no. In 2025, it ranked 8 of 21.
Newest year first. Green marks a year in which the fund came out ahead of HLN; gray means the two finished within a fraction of a point. The rank row places HLN among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of HLN | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| HLN This pageHaleon plc | — | +7.8% | +18.1% | +4.1% |
| Rank among alternatives | Top quarter in 1 of 3 | 8 of 21 | 4 of 21 | 8 of 20 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 3 of 3 | +17.7% | +24.9% | +26.2% |
| TGT Target Corporation | 0 of 3 | −24.5% | −2.3% | −1.4% |
| CL Colgate-Palmolive Company | 0 of 3 | −11.0% | +16.6% | +3.8% |
| WMT Walmart Inc. | 3 of 3 | +24.5% | +74.0% | +12.9% |
| CVS CVS Health Corp. | 1 of 3 | +84.3% | −40.8% | −12.5% |
| GSK GSK plc | 2 of 3 | +51.3% | −5.2% | +9.8% |
| CHD Church & Dwight Co., Inc. | 1 of 3 | −18.9% | +12.0% | +18.7% |
| PG The Procter & Gamble Company | 0 of 3 | −12.3% | +17.3% | −0.9% |
| PFE Pfizer Inc. | 0 of 3 | +0.6% | −2.2% | −41.3% |
| HLF Herbalife Nutrition Ltd. | 1 of 3 | +92.7% | −56.2% | +2.5% |
| NWL Newell Brands Inc. | 1 of 3 | −60.5% | +18.9% | −30.9% |
| PRGO Perrigo Company plc | 0 of 3 | −42.8% | −16.9% | −2.5% |
| KVUE Kenvue Inc. | 0 of 2 | −15.8% | +3.1% | — |
| ELF e.l.f. Beauty, Inc. | 1 of 3 | −39.4% | −13.0% | +161% |
| COTY Coty Inc. | 1 of 3 | −55.8% | −44.0% | +45.1% |
| EL The Estée Lauder Companies Inc. | 1 of 3 | +42.1% | −47.6% | −40.1% |
| PBH Prestige Consumer Healthcare Inc. | 1 of 3 | −21.0% | +27.6% | −2.2% |
| CLX The Clorox Company | 1 of 3 | −35.6% | +17.7% | +5.0% |
| NATR Nature's Sunshine Products, Inc. | 2 of 3 | +47.2% | −15.2% | +108% |
| NUS Nu Skin Enterprises, Inc. | 1 of 3 | +43.3% | −63.7% | −51.0% |
| USNA USANA Health Sciences, Inc. | 0 of 3 | −45.3% | −33.0% | +0.8% |
Risk and diversification
How HLN has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were HLN's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents HLN's five deepest drawdowns since it began trading in 2022, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
Note: HLN began trading on July 18, 2022, so this list cannot include the dot-com bust, the 2008 financial crisis or six other sell-offs. The crash tests on this page show how older funds and the S&P 500 fared through those years.
- In all five of HLN's worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: HLN fell 24.9% from July to September 2022, while the S&P 500 rose 2.7%.
- None of these declines kept HLN below its old high for long; the longest climb back took nine months.
Green means HLN fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | HLN fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| 2022 bear market | −24.9% | +2.7% | Jul 2022 | Sep 2022 | 2 months | Dec 2022 | 3 months |
| No named crash | −23.3% | +29.6% | Jun 2025 | Jun 2026 | 12 months | Not yet | — |
| No named crash | −15.7% | +2.7% | Oct 2024 | Jan 2025 | 3 months | May 2025 | 4 months |
| No named crash | −13.2% | +0.4% | Apr 2023 | Oct 2023 | 6 months | Jul 2024 | 9 months |
| 2023 regional bank crisis | −8.2% | −5.4% | Feb 2023 | Mar 2023 | 1 month | Mar 2023 | Under a month |
How did HLN do in stock market crashes?
This section measures how far HLN, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
Note: HLN began trading on July 18, 2022, so its row reads "Not yet trading" for the dot-com bust, the 2008 financial crisis or seven other sell-offs. The older alternatives and the S&P 500 show how those crashes played out.
- HLN began trading after the 2008 financial crisis, but 16 of its popular alternatives lived through it. The mildest fall among them was WMT's 26.2%, against 55.2% for the S&P 500.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than HLN.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLN This pageHaleon plc | — | −2.4% | Not yet trading | Not yet trading | Not yet trading | Not yet trading | Not yet trading | Not yet trading | Not yet trading | Not yet trading | Not yet trading |
| SPY S&P 500State Street SPDR S&P 500 ETF | 0 of 1 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| TGT Target Corporation | 0 of 1 | −3.4% | −43.9% | −21.7% | −30.3% | −3.0% | −15.8% | −10.4% | −1.3% | −60.6% | −42.6% |
| CL Colgate-Palmolive Company | 1 of 1 | −0.9% | −18.2% | −20.7% | −15.7% | −4.8% | −12.2% | −8.5% | −1.9% | −31.1% | −30.8% |
| WMT Walmart Inc. | 1 of 1 | −0.8% | −25.7% | −13.1% | −18.3% | −4.9% | −22.3% | −10.5% | −1.5% | −26.2% | −31.8% |
| CVS CVS Health Corp. | 0 of 1 | −4.4% | −19.9% | −27.3% | −22.1% | −9.2% | −16.9% | −14.2% | −1.1% | −45.3% | −62.4% |
| GSK GSK plc | 1 of 1 | −0.3% | −37.6% | −26.5% | −11.5% | −4.3% | −15.7% | −12.4% | −2.0% | −46.6% | −45.1% |
| CHD Church & Dwight Co., Inc. | 1 of 1 | 0.0% | −31.7% | −21.1% | −9.4% | −1.1% | −13.3% | −12.4% | −1.5% | −28.0% | −23.6% |
| PG The Procter & Gamble Company | 1 of 1 | −0.7% | −23.8% | −22.9% | −9.6% | −5.1% | −10.9% | −8.9% | −0.7% | −39.0% | −27.1% |
| PFE Pfizer Inc. | 1 of 1 | −1.8% | −24.6% | −21.8% | −12.3% | −8.1% | −18.2% | −16.1% | −1.8% | −49.8% | −46.0% |
| HLF Herbalife Nutrition Ltd. | 0 of 1 | −7.8% | −56.6% | −39.5% | −7.5% | −2.4% | −28.6% | −18.2% | −0.8% | −74.5% | — |
| NWL Newell Brands Inc. | 0 of 1 | −12.1% | −44.9% | −46.2% | −29.5% | −6.7% | −29.9% | −27.8% | −2.2% | −83.2% | −33.9% |
| PRGO Perrigo Company plc | 0 of 1 | −4.1% | −22.5% | −32.9% | −51.3% | −6.6% | −31.4% | −17.6% | −3.0% | −55.1% | −48.2% |
| ELF e.l.f. Beauty, Inc. | 0 of 1 | −6.0% | −35.3% | −58.4% | −41.7% | −4.8% | — | — | — | — | — |
| COTY Coty Inc. | 0 of 1 | −5.4% | −43.5% | −67.5% | −52.6% | −4.3% | −28.2% | — | — | — | — |
| EL The Estée Lauder Companies Inc. | 0 of 1 | −5.4% | −42.0% | −32.1% | −19.8% | −4.2% | −16.1% | −21.5% | −3.7% | −62.1% | −50.7% |
| PBH Prestige Consumer Healthcare Inc. | 1 of 1 | −0.6% | −21.3% | −30.6% | −29.1% | −9.4% | −17.6% | −37.8% | −5.2% | −64.8% | — |
| CLX The Clorox Company | 1 of 1 | −1.2% | −33.4% | −14.0% | −12.6% | −3.0% | −8.6% | −13.2% | −1.5% | −28.4% | −37.3% |
| NATR Nature's Sunshine Products, Inc. | 0 of 1 | −10.4% | −57.6% | −41.3% | −26.0% | −2.2% | −42.9% | −37.5% | −6.3% | — | — |
| NUS Nu Skin Enterprises, Inc. | 1 of 1 | −1.3% | −38.6% | −57.4% | −33.6% | −4.7% | −36.3% | −14.3% | 0.0% | −57.6% | −52.4% |
| USNA USANA Health Sciences, Inc. | 1 of 1 | −0.8% | −45.7% | −38.9% | −15.0% | −3.9% | −42.2% | −25.7% | −1.8% | −62.4% | −80.7% |
How closely does HLN move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares HLN with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 3 years.
- Over the past 3 years, HLN captured 33% of the S&P 500's gains in rising months and 68% of its losses in falling months, with a beta of 0.04. Its share of the market's losses was larger than its share of the gains.
- GSK took just -15% of the S&P 500's losses, against 68% for HLN, while still keeping 42% of its gains.
- Four of the 17 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than HLN's 0.48, led by CL, TGT and CVS.
Monthly total returns over the past 3 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than HLN's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| HLN This pageHaleon plc | 33% | 68% | 0.48 | 0.04 |
| CL Colgate-Palmolive Company | 40% | 39% | 1.03 | 0.27 |
| TGT Target Corporation | 89% | 123% | 0.72 | 0.81 |
| CVS CVS Health Corp. | 79% | 146% | 0.54 | 0.91 |
| PG The Procter & Gamble Company | 20% | 42% | 0.49 | 0.34 |
| CHD Church & Dwight Co., Inc. | 30% | 81% | 0.37 | 0.42 |
| PFE Pfizer Inc. | 36% | 111% | 0.33 | 0.17 |
| KVUE Kenvue Inc. | 21% | 71% | 0.30 | 0.34 |
| ELF e.l.f. Beauty, Inc. | 111% | 404% | 0.27 | 3.26 |
| EL The Estée Lauder Companies Inc. | 130% | 574% | 0.23 | 1.88 |
| NWL Newell Brands Inc. | 28% | 251% | 0.11 | 0.98 |
| NATR Nature's Sunshine Products, Inc. | 18% | 168% | 0.10 | 0.60 |
| CLX The Clorox Company | 14% | 194% | 0.07 | 0.67 |
| COTY Coty Inc. | -4% | 535% | -0.01 | 1.63 |
| PRGO Perrigo Company plc | -8% | 210% | -0.04 | 1.01 |
| PBH Prestige Consumer Healthcare Inc. | -4% | 76% | -0.05 | 0.10 |
| NUS Nu Skin Enterprises, Inc. | -47% | 400% | -0.12 | 0.98 |
| USNA USANA Health Sciences, Inc. | -78% | 277% | -0.28 | 1.16 |
| WMT Walmart Inc. | 80% | -3% | — | 0.38 |
| GSK GSK plc | 42% | -15% | — | -0.01 |
| HLF Herbalife Nutrition Ltd. | -25% | -33% | — | -0.10 |
What diversifies HLN?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with HLN's. Because such investments tend not to fall at the same time, pairing HLN with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in HLN into CLSE would have cut the portfolio's volatility by 21% over the past 3 years and raised its annual return (+4.0% for HLN alone, +9.3% for the mix).
- Among large ETFs, CLSE, SEIV and IDV have moved largely independently of HLN over the past 3 years, with correlations of 0.48 or lower, and each still earned a positive 3-year return.
- Among large stocks, CM, BNY and RY have moved largely independently of HLN over the past 3 years, with correlations of 0.26 or lower, and each still earned a positive 3-year return.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 3 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The last two columns show a portfolio that is 80% HLN and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 3Y return | Sharpe | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|
| HLN Haleon plc (this page) | 1.00 | +30.8% | 0.52 | 20.9% | +4.0% |
| CLSE Broad MarketConvergence Long/Short Equity ETF | -0.14 | +112% | 1.89 | 16.5% | +9.3% |
| SEIV Broad MarketSEI QiM U.S. Large Cap Value Active ETF | 0.16 | +117% | 1.83 | 17.3% | +8.7% |
| IDV InternationaliShares International Select Dividend ETF | 0.48 | +105% | 1.83 | 18.1% | +8.3% |
| INCM Multi-AssetFranklin Income Focus ETF | 0.38 | +45.2% | 1.77 | 17.3% | +5.8% |
| VLUE Broad MarketiShares MSCI USA Value Factor ETF | 0.01 | +139% | 1.73 | 17.2% | +10.0% |
| CGDV Dividend & IncomeCapital Group Dividend Value ETF | 0.21 | +96.5% | 1.72 | 17.4% | +8.3% |
| FMAR Multi-AssetFT Vest U.S. Equity Buffer ETF - March | 0.01 | +53.9% | 1.70 | 16.8% | +6.6% |
| VTV Broad MarketVanguard Morningstar Value ETF | 0.33 | +80.9% | 1.69 | 17.6% | +7.2% |
Stocks
| Investment | Correlation | 3Y return | Sharpe | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|
| HLN Haleon plc (this page) | 1.00 | +30.8% | 0.52 | 20.9% | +4.0% |
| CM Banks - DiversifiedCanadian Imperial Bank of Commerce | 0.24 | +265% | 2.29 | 18.5% | +12.4% |
| BNY Investment - Banking & Investment ServicesBank of New York Mellon Corp | 0.18 | +277% | 2.21 | 17.8% | +13.2% |
| RY Banks - DiversifiedRoyal Bank of Canada | 0.26 | +176% | 2.09 | 18.2% | +10.3% |
| TIGO Telecommunications ServicesMillicom International Cellular S.A. | 0.19 | +545% | 1.99 | 18.5% | +18.3% |
| CIB Banks - RegionalGrupo Cibest S.A. | 0.12 | +405% | 1.97 | 18.6% | +15.5% |
Common questions
What was HLN's worst drawdown?
HLN's deepest decline since it began trading in 2022 was 24.9%, from July to September 2022. It took three months from the low to climb back to its old high. Because HLN launched in July 2022, that record does not include the dot-com bust, the 2008 financial crisis or six other sell-offs.
What were HLN's best and worst years?
Over three full calendar years, HLN's best year was 2024, when it returned 18.1%. Its worst was 2023, with a return of +4.1%.
Is there a better investment than HLN?
Among HLN's popular alternatives, CL earned more than HLN with less volatility over the past 3 years: 13.2% a year at 19.9% volatility, against 9.4% a year at 21.6%. Looking beyond its popular alternatives, JNJ (pharmaceuticals) and COST (discount retail) earned more than HLN with less volatility over the past 3 years. JNJ returned 24.4% a year at 18.5% volatility, against 9.4% a year at 21.6%.
Is HLN more volatile than the S&P 500?
Yes. HLN's volatility over the past 3 years was 21.6%, 1.4 times the S&P 500's 15.2%. Volatility measures how widely returns swing around their average: in roughly two years out of three, HLN's return lands within 21.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is HLN's Sharpe ratio?
HLN's Sharpe ratio over the past 3 years was 0.52, against 1.47 for the S&P 500, so HLN earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is HLN with the S&P 500?
Over the past 3 years, HLN's monthly returns had a correlation of 0.02 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are close to unrelated, or move in opposite directions, so it can steady a stock portfolio. In the table, the correlation column measures each option against HLN instead: the lower it is, the more that option would diversify a HLN holding.
What are the best alternatives to HLN?
Of the 20 popular alternatives we compared, four outperformed HLN in at least 3 of 5 short-term and 1 of 1 long-term timeframes, with dividends reinvested: TGT, CL and WMT.
Did HLN outperform the S&P 500?
HLN finished ahead of the S&P 500 (SPY) in no of three full calendar years. In 2025, it returned +7.8%, against +17.7% for the index.
What diversifies HLN?
These had a low correlation with HLN over the past 3 years and still earned a positive 3-year return: among large ETFs, CLSE (correlation -0.14), SEIV (correlation 0.16) and IDV (correlation 0.48); among large stocks, CM (correlation 0.24), BNY (correlation 0.18) and RY (correlation 0.26). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than HLN's. Returns within 0.5 points or 3% of HLN's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 1 of 1 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 3 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to HLN
TGTTarget
CLColgate-Palmolive
WMTWalmart
CVSCVS Health
GSKGSK
PGProcter & Gamble
PFEPfizer
ELEstée Lauder Companies